445 related articles for article (PubMed ID: 29636029)
21. Neurodevelopmental outcomes at 9-14 months gestational age after treatment of neonatal seizures due to brain injury.
Ghosh S; Cabassa Miskimen AC; Brady J; Robinson MA; Zou B; Weiss M; Kang PB
Childs Nerv Syst; 2019 Sep; 35(9):1571-1578. PubMed ID: 31278442
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetic and Pharmacodynamic Evaluation of Intravenous Levetiracetam in Children With Epilepsy.
Kim MJ; Yum MS; Yeh HR; Ko TS; Lim HS
J Clin Pharmacol; 2018 Dec; 58(12):1586-1596. PubMed ID: 30052270
[TBL] [Abstract][Full Text] [Related]
23. Is the anticonvulsant activity of levetiracetam dose-dependent?
Lamouret V; Kurth C; Intravooth T; Steinhoff BJ
Seizure; 2020 Dec; 83():197-202. PubMed ID: 33197757
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of Levetiracetam and Phenobarbital as First-Line Treatment for Neonatal Seizures.
Verwoerd C; Limjoco J; Rajamanickam V; Knox A
J Child Neurol; 2022 Apr; 37(5):401-409. PubMed ID: 35311411
[TBL] [Abstract][Full Text] [Related]
25. Levetiracetam for the Treatment of Seizures in Neonatal Hypoxic Ischemic Encephalopathy.
Venkatesan C; Young S; Schapiro M; Thomas C
J Child Neurol; 2017 Feb; 32(2):210-214. PubMed ID: 27872177
[TBL] [Abstract][Full Text] [Related]
26. Favorable adverse effect profile of brivaracetam vs levetiracetam in a preclinical model.
Sanon NT; Gagné J; Wolf DC; Aboulamer S; Bosoi CM; Simard A; Messiet E; Desgent S; Carmant L
Epilepsy Behav; 2018 Feb; 79():117-125. PubMed ID: 29287214
[TBL] [Abstract][Full Text] [Related]
27. Short-Term Neurodevelopmental Outcome in Term Neonates Treated with Phenobarbital versus Levetiracetam: A Single-Center Experience.
Falsaperla R; Mauceri L; Pavone P; Barbagallo M; Vitaliti G; Ruggieri M; Pisani F; Corsello G
Behav Neurol; 2019; 2019():3683548. PubMed ID: 31281546
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and safety of levetiracetam in the off-label treatment of neonatal seizures.
Liu BK; Jiang L; Li XJ; Hong SQ; Chen W; Hu Y
Int J Neurosci; 2020 Apr; 130(4):336-342. PubMed ID: 31665950
[No Abstract] [Full Text] [Related]
29. Eslicarbazepine acetate as a replacement for levetiracetam in people with epilepsy developing behavioral adverse events.
Jalihal V; Shankar R; Henley W; Parrett M; Tittensor P; McLean BN; Ahmed A; Sander JW
Epilepsy Behav; 2018 Mar; 80():365-369. PubMed ID: 29415871
[TBL] [Abstract][Full Text] [Related]
30. A retrospective comparison of phenobarbital and levetiracetam for the treatment of seizures following cardiac surgery in neonates.
Thibault C; Naim MY; Abend NS; Licht DJ; Gaynor JW; Xiao R; Massey SL
Epilepsia; 2020 Apr; 61(4):627-635. PubMed ID: 32162678
[TBL] [Abstract][Full Text] [Related]
31. Association between anti-seizure medication and outcomes in infants.
Sewell EK; Hamrick SEG; Patel RM; Bennett M; Tolia VN; Ahmad KA
J Perinatol; 2022 Mar; 42(3):359-364. PubMed ID: 34671100
[TBL] [Abstract][Full Text] [Related]
32. A Systematic Review of the Efficacy of Levetiracetam in Neonatal Seizures.
McHugh DC; Lancaster S; Manganas LN
Neuropediatrics; 2018 Feb; 49(1):12-17. PubMed ID: 29179233
[TBL] [Abstract][Full Text] [Related]
33. High-Dose Levetiracetam for Neonatal Seizures: A Retrospective Review.
Hnaini M; Darwich M; Koleilat N; Jaafar F; Hanneyan S; Rahal S; Mikati IE; Shbarou RM; Nabout R; Maalouf FI; Obeid M
Seizure; 2020 Nov; 82():7-11. PubMed ID: 32950862
[TBL] [Abstract][Full Text] [Related]
34. Usefulness of perampanel with concomitant levetiracetam for patients with drug-resistant epilepsy.
Kanemura H; Sano F; Aihara M
Eur J Paediatr Neurol; 2019 Jan; 23(1):197-203. PubMed ID: 30424990
[TBL] [Abstract][Full Text] [Related]
35. Neonatal Antiepileptic Medication Treatment Patterns: A Decade of Change.
Le VT; Abdi HH; Sánchez PJ; Yossef L; Reagan PB; Slaughter LA; Firestine A; Slaughter JL
Am J Perinatol; 2021 Apr; 38(5):469-476. PubMed ID: 31600794
[TBL] [Abstract][Full Text] [Related]
36. Levetiracetam for the treatment of neonatal seizures.
Shoemaker MT; Rotenberg JS
J Child Neurol; 2007 Jan; 22(1):95-8. PubMed ID: 17608315
[TBL] [Abstract][Full Text] [Related]
37. The effect of serum levetiracetam concentrations on therapeutic response and IL1-beta concentration in patients with epilepsy.
Gulcebi MI; Kendirli T; Turgan ZA; Patsalos PN; Onat Yilmaz F
Epilepsy Res; 2018 Dec; 148():17-22. PubMed ID: 30326332
[TBL] [Abstract][Full Text] [Related]
38. [Paradoxical effect of levetiracetam on seizure suppression: three cases showing U curve association between dose and effect].
Inoue T; Kobayashi K; Usami K; Shimotake A; Inouchi M; Sakai T; Ikeda A; Takahashi R
Rinsho Shinkeigaku; 2021 Apr; 61(4):247-252. PubMed ID: 33762498
[TBL] [Abstract][Full Text] [Related]
39. Levetiracetam as the first-line treatment for neonatal seizures: a systematic review and meta-analysis.
Hooper RG; Ramaswamy VV; Wahid RM; Satodia P; Bhulani A
Dev Med Child Neurol; 2021 Nov; 63(11):1283-1293. PubMed ID: 34124790
[TBL] [Abstract][Full Text] [Related]
40. Lidocaine response rate in aEEG-confirmed neonatal seizures: Retrospective study of 413 full-term and preterm infants.
Weeke LC; Toet MC; van Rooij LG; Groenendaal F; Boylan GB; Pressler RM; Hellström-Westas L; van den Broek MP; de Vries LS
Epilepsia; 2016 Feb; 57(2):233-42. PubMed ID: 26719344
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
